Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination - Does abacavir play a role?

被引：61

作者：

Bani-Sadr, Firouze ^{[1
]}

Denoeud, Lise

Morand, Patrice

Lunel-Fabiani, Francoise

Pol, Stanislas

Cacoub, Patrice

Perronne, Christian

Carrat, Fabrice

机构：

[1] Univ Paris 06, Grp Hosp Univ Est, INSERM U707, Paris, France

[2] CHU Grenoble, F-38043 Grenoble, France

[3] Fac Med, Angers, France

[4] Univ Paris 05, Grp Hosp Univ Ouest, INSERM U370, Paris, France

[5] Univ Paris 06, Grp Hosp Univ Est, UMR 7087, Paris, France

[6] Univ Versailles, CHU Raymond Poincare, Garches, France

来源：

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2007年 / 45卷 / 01期

关键词：

D O I：

10.1097/QAI.0b013e318040b2b6

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：123 / 125

页数：3

共 8 条

[1] Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load [J].

Akuta, N ;

Suzuki, F ;

Sezaki, H ;

Suzuki, Y ;

Hosaka, T ;

Someya, T ;

Kobayashi, M ;

Saitoh, S ;

Watahiki, S ;

Sato, J ;

Kobayashi, M ;

Arase, Y ;

Ikeda, K ;

Kumada, H .

JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (01) :83-90

[2] Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients -: A randomized controlled trial [J].

Carrat, F ;

Bani-Sadr, F ;

Pol, S ;

Rosenthal, E ;

Lunel-Fabiani, F ;

Benzekri, A ;

Morand, P ;

Goujard, C ;

Pialoux, G ;

Piroth, L ;

Salmon-Céron, D ;

Degott, C ;

Cacoub, P ;

Perronne, C .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (23) :2839-2848

[3] Pharmacokinetics, pharmacodynamics, and hepatitis C viral kinetics during antiviral therapy: The null responder [J].

Di Bisceglie, AM ;

Fan, XF ;

Chambers, T ;

Strinko, J .

JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (04) :446-451

[4] Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjects [J].

Gallant, JE ;

Rodriguez, AE ;

Weinberg, WG ;

Young, B ;

Berger, DS ;

Lim, ML ;

Liao, QM ;

Ross, L ;

Johnson, J ;

Shaefer, MS .

JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (11) :1921-1930

[5] Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimens [J].

Hawkins, T ;

Veikley, W ;

St Claire, RL ;

Guyer, B ;

Clark, N ;

Kearney, BP .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (04) :406-411

[6]

Kakuda TN, 2004, AIDS, V18, P2442

[7]

Margot NA, 2005, ANTIVIR THER, V10, P343

[8] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients [J].

Torriani, FJ ;

Rodriguez-Torres, M ;

Rockstroh, JK ;

Lissen, E ;

Gonzalez-García, J ;

Lazzarin, A ;

Carosi, G ;

Sasadeusz, J ;

Katlama, C ;

Montaner, J ;

Sette, HJ ;

Passe, S ;

De Pamphilis, J ;

Duff, F ;

Schrenk, UM ;

Dieterich, DT .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05) :438-450

← 1 →